 Makoto Miyazaki
Concepts (577)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stearoyl-CoA Desaturase | 43 | 2026 | 66 | 4.640 |
Why?
| | Vascular Calcification | 9 | 2022 | 109 | 3.890 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2024 | 639 | 2.190 |
Why?
| | Endoplasmic Reticulum | 6 | 2025 | 268 | 1.700 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 9 | 2018 | 210 | 1.620 |
Why?
| | Atherosclerosis | 8 | 2021 | 410 | 1.590 |
Why?
| | Activating Transcription Factor 4 | 5 | 2021 | 22 | 1.560 |
Why?
| | Transcription Factor CHOP | 4 | 2018 | 32 | 1.450 |
Why?
| | Bile Acids and Salts | 3 | 2018 | 162 | 1.350 |
Why?
| | Autophagy | 6 | 2025 | 290 | 1.320 |
Why?
| | Fatty Acids | 20 | 2026 | 460 | 1.200 |
Why?
| | Liver | 22 | 2026 | 1859 | 1.160 |
Why?
| | Endoplasmic Reticulum Stress | 4 | 2021 | 120 | 1.080 |
Why?
| | Calcinosis | 4 | 2014 | 231 | 1.000 |
Why?
| | Mice | 75 | 2026 | 18266 | 0.980 |
Why?
| | Membrane Proteins | 4 | 2025 | 1130 | 0.970 |
Why?
| | Lipids | 12 | 2022 | 715 | 0.890 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2018 | 232 | 0.830 |
Why?
| | Adverse Drug Reaction Reporting Systems | 3 | 2021 | 81 | 0.820 |
Why?
| | Animals | 84 | 2026 | 38030 | 0.770 |
Why?
| | Deoxycholic Acid | 3 | 2022 | 14 | 0.740 |
Why?
| | Kidney | 10 | 2025 | 1491 | 0.720 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.720 |
Why?
| | Mice, Knockout | 30 | 2026 | 3121 | 0.710 |
Why?
| | Stearic Acids | 2 | 2012 | 15 | 0.700 |
Why?
| | Leptin | 9 | 2010 | 247 | 0.700 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2025 | 456 | 0.650 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2018 | 271 | 0.610 |
Why?
| | Vascular Diseases | 2 | 2014 | 251 | 0.590 |
Why?
| | Starvation | 1 | 2019 | 21 | 0.580 |
Why?
| | Isoenzymes | 6 | 2006 | 294 | 0.580 |
Why?
| | Vascular Stiffness | 1 | 2024 | 488 | 0.570 |
Why?
| | Autistic Disorder | 1 | 2022 | 215 | 0.570 |
Why?
| | Cyclin T | 1 | 2018 | 2 | 0.570 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2018 | 17 | 0.560 |
Why?
| | Mice, Inbred C57BL | 27 | 2026 | 6021 | 0.560 |
Why?
| | Lipid Metabolism | 15 | 2018 | 533 | 0.550 |
Why?
| | Metabolomics | 2 | 2026 | 737 | 0.510 |
Why?
| | Energy Metabolism | 5 | 2026 | 930 | 0.500 |
Why?
| | Kidney Diseases | 4 | 2019 | 427 | 0.500 |
Why?
| | Apolipoproteins E | 4 | 2014 | 97 | 0.490 |
Why?
| | Triglycerides | 12 | 2026 | 527 | 0.490 |
Why?
| | Coronary Vessels | 2 | 2022 | 245 | 0.480 |
Why?
| | eIF-2 Kinase | 2 | 2013 | 29 | 0.480 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 404 | 0.480 |
Why?
| | Cholesterol | 8 | 2016 | 410 | 0.480 |
Why?
| | Lipogenesis | 4 | 2012 | 62 | 0.470 |
Why?
| | Vaccines | 1 | 2021 | 389 | 0.460 |
Why?
| | Japan | 8 | 2026 | 149 | 0.450 |
Why?
| | Phosphatidylethanolamines | 1 | 2015 | 78 | 0.450 |
Why?
| | Coronary Artery Disease | 2 | 2022 | 751 | 0.440 |
Why?
| | Acute Kidney Injury | 4 | 2026 | 861 | 0.420 |
Why?
| | Fukushima Nuclear Accident | 3 | 2020 | 3 | 0.410 |
Why?
| | Fatty Acid Desaturases | 2 | 2006 | 32 | 0.410 |
Why?
| | Osteogenesis | 4 | 2021 | 204 | 0.400 |
Why?
| | Disease Models, Animal | 15 | 2026 | 4565 | 0.400 |
Why?
| | Polycystic Kidney Diseases | 2 | 2025 | 82 | 0.400 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 5 | 2020 | 36 | 0.390 |
Why?
| | Signal Transduction | 15 | 2024 | 5234 | 0.390 |
Why?
| | Pharmacovigilance | 3 | 2026 | 25 | 0.380 |
Why?
| | Blood Vessels | 2 | 2011 | 164 | 0.380 |
Why?
| | Dietary Fats | 5 | 2007 | 307 | 0.370 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2019 | 33 | 0.350 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2025 | 454 | 0.350 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2024 | 449 | 0.340 |
Why?
| | Cells, Cultured | 12 | 2019 | 4112 | 0.330 |
Why?
| | Cisplatin | 3 | 2020 | 346 | 0.320 |
Why?
| | Transcription Factors | 6 | 2006 | 1728 | 0.320 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2591 | 0.320 |
Why?
| | Amino Acids | 3 | 2026 | 513 | 0.310 |
Why?
| | Fatty Liver | 3 | 2012 | 251 | 0.310 |
Why?
| | Diet | 5 | 2022 | 1271 | 0.310 |
Why?
| | Humans | 50 | 2026 | 145625 | 0.300 |
Why?
| | DNA-Binding Proteins | 7 | 2008 | 1467 | 0.290 |
Why?
| | Male | 44 | 2026 | 73014 | 0.290 |
Why?
| | Phosphorylation | 9 | 2018 | 1717 | 0.290 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 9 | 2011 | 56 | 0.280 |
Why?
| | Mice, Transgenic | 7 | 2018 | 2131 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1223 | 0.280 |
Why?
| | Protein Isoforms | 5 | 2019 | 388 | 0.270 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 2 | 2024 | 244 | 0.270 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2218 | 0.270 |
Why?
| | Inflammation | 6 | 2021 | 2915 | 0.270 |
Why?
| | Adiposity | 3 | 2010 | 531 | 0.260 |
Why?
| | Orphan Nuclear Receptors | 5 | 2012 | 14 | 0.260 |
Why?
| | Oleic Acid | 4 | 2009 | 40 | 0.260 |
Why?
| | Mice, Inbred DBA | 2 | 2018 | 185 | 0.260 |
Why?
| | Macrophages | 6 | 2021 | 1530 | 0.260 |
Why?
| | Cell Proliferation | 4 | 2024 | 2497 | 0.240 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 192 | 0.240 |
Why?
| | Myocardium | 4 | 2010 | 948 | 0.240 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1429 | 0.230 |
Why?
| | Receptors, LDL | 2 | 2018 | 53 | 0.230 |
Why?
| | Insulin Resistance | 3 | 2009 | 1247 | 0.230 |
Why?
| | Obesity | 8 | 2010 | 3123 | 0.220 |
Why?
| | Fructokinases | 2 | 2016 | 42 | 0.220 |
Why?
| | Epithelial Cells | 4 | 2019 | 1118 | 0.220 |
Why?
| | Lymphoid Tissue | 1 | 2025 | 82 | 0.210 |
Why?
| | Tetraspanins | 2 | 2014 | 19 | 0.210 |
Why?
| | Uric Acid | 2 | 2024 | 167 | 0.210 |
Why?
| | Salmonella Infections | 1 | 2025 | 58 | 0.210 |
Why?
| | Urate Oxidase | 1 | 2024 | 12 | 0.210 |
Why?
| | Adipose Tissue | 4 | 2010 | 641 | 0.210 |
Why?
| | Deoxyglucose | 1 | 2024 | 51 | 0.210 |
Why?
| | Muscle, Skeletal | 6 | 2026 | 1795 | 0.200 |
Why?
| | Cell Line | 5 | 2018 | 2809 | 0.200 |
Why?
| | Glomerulonephritis | 2 | 2021 | 46 | 0.200 |
Why?
| | Intestine, Small | 2 | 2026 | 160 | 0.190 |
Why?
| | Fructose | 1 | 2004 | 132 | 0.190 |
Why?
| | Salmonella typhimurium | 1 | 2025 | 193 | 0.190 |
Why?
| | Liver X Receptors | 5 | 2012 | 29 | 0.190 |
Why?
| | Sebaceous Glands | 1 | 2002 | 4 | 0.190 |
Why?
| | Kidney Tubules, Proximal | 2 | 2022 | 127 | 0.190 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2005 | 97 | 0.190 |
Why?
| | Fibroblasts | 2 | 2021 | 1033 | 0.190 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2012 | 266 | 0.180 |
Why?
| | Ischemia | 1 | 2026 | 421 | 0.180 |
Why?
| | Evidence-Based Medicine | 1 | 2026 | 727 | 0.180 |
Why?
| | Isothiocyanates | 1 | 2022 | 4 | 0.180 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2022 | 6 | 0.180 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2022 | 9 | 0.180 |
Why?
| | Metabolome | 1 | 2026 | 390 | 0.180 |
Why?
| | Lysosomes | 2 | 2021 | 133 | 0.180 |
Why?
| | Integrin alpha5 | 1 | 2021 | 2 | 0.180 |
Why?
| | Biomarkers | 5 | 2025 | 4329 | 0.180 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 8 | 0.170 |
Why?
| | Multienzyme Complexes | 4 | 2005 | 65 | 0.170 |
Why?
| | Calibration | 1 | 2022 | 154 | 0.170 |
Why?
| | Judgment | 1 | 2022 | 59 | 0.170 |
Why?
| | Parathyroid Hormone | 1 | 2022 | 118 | 0.170 |
Why?
| | Dyslipidemias | 2 | 2022 | 184 | 0.170 |
Why?
| | Phosphates | 1 | 2022 | 175 | 0.170 |
Why?
| | Chernobyl Nuclear Accident | 1 | 2020 | 5 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.160 |
Why?
| | Kidney Glomerulus | 2 | 2019 | 129 | 0.160 |
Why?
| | Fibroblast Growth Factors | 1 | 2022 | 187 | 0.160 |
Why?
| | Anticholesteremic Agents | 2 | 2012 | 156 | 0.160 |
Why?
| | Spectrum Analysis, Raman | 2 | 2011 | 36 | 0.160 |
Why?
| | Skin | 1 | 2005 | 701 | 0.160 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2088 | 0.160 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2020 | 8 | 0.160 |
Why?
| | Podocytes | 2 | 2019 | 80 | 0.160 |
Why?
| | Homeostasis | 2 | 2021 | 646 | 0.150 |
Why?
| | NF-kappa B | 1 | 2024 | 674 | 0.150 |
Why?
| | Intestinal Mucosa | 1 | 2026 | 666 | 0.150 |
Why?
| | Tissue Distribution | 3 | 2007 | 334 | 0.150 |
Why?
| | Cattle | 3 | 2011 | 938 | 0.150 |
Why?
| | Down-Regulation | 4 | 2008 | 612 | 0.150 |
Why?
| | Stomach Neoplasms | 1 | 2021 | 128 | 0.150 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 122 | 0.150 |
Why?
| | Bayes Theorem | 1 | 2022 | 424 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 126 | 0.150 |
Why?
| | Hepatocytes | 2 | 2019 | 224 | 0.150 |
Why?
| | HeLa Cells | 5 | 2025 | 635 | 0.140 |
Why?
| | Tretinoin | 1 | 2020 | 114 | 0.140 |
Why?
| | Kidney Failure, Chronic | 1 | 2025 | 582 | 0.140 |
Why?
| | Insulin | 7 | 2009 | 2524 | 0.140 |
Why?
| | Fatty Acids, Monounsaturated | 4 | 2009 | 55 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2022 | 265 | 0.140 |
Why?
| | Blotting, Northern | 6 | 2005 | 197 | 0.140 |
Why?
| | Mitochondria, Liver | 2 | 2012 | 70 | 0.140 |
Why?
| | Heat-Shock Response | 1 | 2019 | 78 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2021 | 172 | 0.140 |
Why?
| | Sepsis | 1 | 2025 | 668 | 0.140 |
Why?
| | Receptors, Fc | 1 | 2019 | 54 | 0.140 |
Why?
| | Carrier Proteins | 2 | 2021 | 728 | 0.140 |
Why?
| | Serum Albumin | 1 | 2019 | 147 | 0.140 |
Why?
| | Osteopontin | 1 | 2018 | 37 | 0.140 |
Why?
| | Bacterial Proteins | 1 | 2025 | 976 | 0.140 |
Why?
| | Radiation Dosimeters | 1 | 2017 | 1 | 0.130 |
Why?
| | Background Radiation | 1 | 2017 | 1 | 0.130 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2018 | 69 | 0.130 |
Why?
| | TRPP Cation Channels | 3 | 2024 | 76 | 0.130 |
Why?
| | Rats | 6 | 2024 | 5574 | 0.130 |
Why?
| | Quality Assurance, Health Care | 1 | 2020 | 339 | 0.130 |
Why?
| | Fever | 1 | 2019 | 320 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2019 | 138 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 266 | 0.130 |
Why?
| | Dietary Carbohydrates | 3 | 2007 | 145 | 0.130 |
Why?
| | Interleukin-33 | 1 | 2017 | 45 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 207 | 0.130 |
Why?
| | Databases, Factual | 2 | 2020 | 1481 | 0.130 |
Why?
| | Gene Knockdown Techniques | 3 | 2014 | 334 | 0.130 |
Why?
| | Adaptive Immunity | 1 | 2018 | 172 | 0.130 |
Why?
| | Disease Progression | 3 | 2021 | 2857 | 0.130 |
Why?
| | Radiation Exposure | 1 | 2017 | 62 | 0.130 |
Why?
| | Chelating Agents | 1 | 2017 | 75 | 0.130 |
Why?
| | Phosphorus | 1 | 2017 | 89 | 0.130 |
Why?
| | Ion Pumps | 1 | 2016 | 1 | 0.120 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 834 | 0.120 |
Why?
| | Mice, Mutant Strains | 4 | 2012 | 290 | 0.120 |
Why?
| | Female | 26 | 2025 | 79080 | 0.120 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 69 | 0.120 |
Why?
| | Hypertriglyceridemia | 3 | 2008 | 45 | 0.120 |
Why?
| | Adipocytes, White | 2 | 2022 | 19 | 0.120 |
Why?
| | Heart | 4 | 2010 | 624 | 0.120 |
Why?
| | Base Sequence | 4 | 2007 | 2119 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 427 | 0.120 |
Why?
| | Cell Differentiation | 4 | 2012 | 1979 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2016 | 152 | 0.110 |
Why?
| | Diet, Fat-Restricted | 2 | 2006 | 79 | 0.110 |
Why?
| | Carbohydrate Metabolism | 2 | 2007 | 59 | 0.110 |
Why?
| | Radiation Monitoring | 1 | 2015 | 14 | 0.110 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 452 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1790 | 0.110 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 199 | 0.110 |
Why?
| | Mitochondria | 3 | 2019 | 996 | 0.110 |
Why?
| | Albuminuria | 1 | 2016 | 190 | 0.110 |
Why?
| | Radiometry | 1 | 2015 | 56 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2026 | 3396 | 0.110 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1236 | 0.110 |
Why?
| | Gamma Rays | 1 | 2015 | 56 | 0.110 |
Why?
| | Hydrocarbons, Fluorinated | 2 | 2012 | 8 | 0.110 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 629 | 0.110 |
Why?
| | Protein Binding | 3 | 2018 | 2239 | 0.110 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.110 |
Why?
| | Lung Neoplasms | 3 | 2020 | 2674 | 0.110 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 364 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2019 | 899 | 0.110 |
Why?
| | Osteoblasts | 2 | 2012 | 145 | 0.100 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 52 | 0.100 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.100 |
Why?
| | Bone Marrow | 1 | 2016 | 308 | 0.100 |
Why?
| | Azetidines | 1 | 2014 | 45 | 0.100 |
Why?
| | Simvastatin | 1 | 2014 | 58 | 0.100 |
Why?
| | Body Weight | 7 | 2010 | 964 | 0.100 |
Why?
| | DNA Damage | 1 | 2017 | 437 | 0.100 |
Why?
| | Health Surveys | 3 | 2022 | 511 | 0.100 |
Why?
| | Dehydration | 1 | 2013 | 59 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 492 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 982 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1270 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1992 | 0.100 |
Why?
| | Cholesterol Ester Transfer Proteins | 1 | 2012 | 22 | 0.090 |
Why?
| | Benzoates | 1 | 2012 | 48 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 767 | 0.090 |
Why?
| | Catechin | 1 | 2012 | 23 | 0.090 |
Why?
| | Isoxazoles | 1 | 2012 | 56 | 0.090 |
Why?
| | Nicorandil | 1 | 2012 | 11 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 929 | 0.090 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 19 | 0.090 |
Why?
| | DNA Primers | 3 | 2007 | 487 | 0.090 |
Why?
| | Minerals | 1 | 2012 | 48 | 0.090 |
Why?
| | Lipoproteins, HDL | 1 | 2012 | 104 | 0.090 |
Why?
| | Middle Aged | 7 | 2025 | 36359 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2017 | 3633 | 0.090 |
Why?
| | Oxidation-Reduction | 5 | 2010 | 1075 | 0.090 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 94 | 0.090 |
Why?
| | Antioxidants | 2 | 2012 | 544 | 0.090 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2011 | 32 | 0.080 |
Why?
| | Mice, Nude | 3 | 2021 | 665 | 0.080 |
Why?
| | Biomedical Research | 1 | 2018 | 724 | 0.080 |
Why?
| | RNA, Messenger | 7 | 2018 | 2783 | 0.080 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1034 | 0.080 |
Why?
| | Molecular Imaging | 1 | 2011 | 58 | 0.080 |
Why?
| | Models, Biological | 5 | 2006 | 1758 | 0.080 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 60 | 0.080 |
Why?
| | Etoposide | 1 | 2011 | 169 | 0.080 |
Why?
| | Glucose | 2 | 2007 | 1051 | 0.080 |
Why?
| | Sulfonamides | 2 | 2012 | 592 | 0.080 |
Why?
| | Aorta | 2 | 2012 | 440 | 0.080 |
Why?
| | Risk Factors | 3 | 2022 | 10840 | 0.080 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 144 | 0.080 |
Why?
| | Chenodeoxycholic Acid | 1 | 2010 | 11 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2012 | 201 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 594 | 0.080 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2218 | 0.080 |
Why?
| | Mice, Obese | 3 | 2006 | 68 | 0.070 |
Why?
| | Diacylglycerol O-Acyltransferase | 2 | 2006 | 5 | 0.070 |
Why?
| | Cell Movement | 1 | 2014 | 950 | 0.070 |
Why?
| | Agouti Signaling Protein | 1 | 2009 | 2 | 0.070 |
Why?
| | Aging | 2 | 2019 | 1983 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2026 | 267 | 0.070 |
Why?
| | Aged | 5 | 2025 | 26251 | 0.070 |
Why?
| | Cholic Acids | 1 | 2008 | 13 | 0.070 |
Why?
| | Gene Silencing | 2 | 2016 | 200 | 0.070 |
Why?
| | Hypercholesterolemia | 2 | 2006 | 95 | 0.070 |
Why?
| | Microscopy | 1 | 2010 | 147 | 0.070 |
Why?
| | Mutation | 6 | 2018 | 4082 | 0.070 |
Why?
| | Ceramides | 2 | 2010 | 114 | 0.070 |
Why?
| | Hyperlipidemia, Familial Combined | 1 | 2008 | 2 | 0.070 |
Why?
| | Transgenes | 2 | 2006 | 178 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2008 | 130 | 0.070 |
Why?
| | Blotting, Western | 6 | 2007 | 1176 | 0.070 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 320 | 0.070 |
Why?
| | Receptor, Insulin | 2 | 2006 | 92 | 0.070 |
Why?
| | Lipocalin-2 | 2 | 2020 | 80 | 0.070 |
Why?
| | Acyltransferases | 2 | 2005 | 78 | 0.070 |
Why?
| | Microsomes | 2 | 2007 | 33 | 0.070 |
Why?
| | Glycogen | 2 | 2004 | 55 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2009 | 360 | 0.060 |
Why?
| | Mycological Typing Techniques | 1 | 2007 | 1 | 0.060 |
Why?
| | Histoplasma | 1 | 2007 | 11 | 0.060 |
Why?
| | Histoplasmosis | 1 | 2007 | 15 | 0.060 |
Why?
| | Tumor Burden | 2 | 2020 | 326 | 0.060 |
Why?
| | Animal Feed | 2 | 2004 | 50 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2007 | 81 | 0.060 |
Why?
| | Adipose Tissue, Brown | 2 | 2004 | 60 | 0.060 |
Why?
| | Time Factors | 4 | 2019 | 7079 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2623 | 0.060 |
Why?
| | Sucrose | 1 | 2007 | 113 | 0.060 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2017 | 530 | 0.060 |
Why?
| | Pedigree | 1 | 2008 | 507 | 0.060 |
Why?
| | Blood Pressure | 4 | 2016 | 1761 | 0.060 |
Why?
| | CD36 Antigens | 1 | 2026 | 32 | 0.060 |
Why?
| | Mice, SCID | 2 | 2004 | 360 | 0.060 |
Why?
| | Child | 3 | 2021 | 22638 | 0.060 |
Why?
| | Lipolysis | 2 | 2022 | 44 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2835 | 0.060 |
Why?
| | Rare Diseases | 1 | 2026 | 115 | 0.060 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2025 | 13 | 0.060 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2005 | 3 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Carnitine O-Palmitoyltransferase | 4 | 2007 | 49 | 0.060 |
Why?
| | Radiation Dosage | 2 | 2017 | 193 | 0.050 |
Why?
| | Receptors, Retinoic Acid | 2 | 2020 | 43 | 0.050 |
Why?
| | Colitis | 1 | 2008 | 280 | 0.050 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2004 | 2 | 0.050 |
Why?
| | Oxypurinol | 1 | 2024 | 3 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 840 | 0.050 |
Why?
| | Structure-Activity Relationship | 2 | 2018 | 561 | 0.050 |
Why?
| | Oxonic Acid | 1 | 2024 | 13 | 0.050 |
Why?
| | Lipodystrophy | 1 | 2004 | 12 | 0.050 |
Why?
| | Thermogenesis | 1 | 2004 | 45 | 0.050 |
Why?
| | Glutathione | 1 | 2026 | 369 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2004 | 44 | 0.050 |
Why?
| | Xanthine Oxidase | 1 | 2024 | 79 | 0.050 |
Why?
| | Chronic Disease | 1 | 2010 | 1824 | 0.050 |
Why?
| | Cholestasis | 1 | 2006 | 215 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2910 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2533 | 0.050 |
Why?
| | Hypothermia | 1 | 2004 | 53 | 0.050 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2003 | 13 | 0.050 |
Why?
| | Transfection | 2 | 2021 | 914 | 0.050 |
Why?
| | Colon | 1 | 2026 | 304 | 0.050 |
Why?
| | Anti-Obesity Agents | 1 | 2004 | 67 | 0.050 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 106 | 0.050 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 112 | 0.050 |
Why?
| | Foam Cells | 2 | 2016 | 17 | 0.050 |
Why?
| | Cell Membrane | 2 | 2005 | 701 | 0.050 |
Why?
| | Chromatography, Gas | 1 | 2002 | 30 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 269 | 0.050 |
Why?
| | Cholesterol, Dietary | 1 | 2002 | 15 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2014 | 503 | 0.050 |
Why?
| | Cold Temperature | 1 | 2004 | 207 | 0.050 |
Why?
| | Inflammasomes | 1 | 2024 | 145 | 0.050 |
Why?
| | Cytokines | 2 | 2024 | 2079 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 382 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2005 | 887 | 0.050 |
Why?
| | Sulfoxides | 1 | 2022 | 4 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 36 | 0.040 |
Why?
| | Thiazolidines | 1 | 2022 | 13 | 0.040 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2003 | 166 | 0.040 |
Why?
| | Protein Transport | 2 | 2019 | 439 | 0.040 |
Why?
| | Dehydroepiandrosterone | 1 | 2002 | 50 | 0.040 |
Why?
| | Apoptosis | 3 | 2020 | 2436 | 0.040 |
Why?
| | Aminopterin | 1 | 2021 | 3 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2025 | 366 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2003 | 242 | 0.040 |
Why?
| | Food | 1 | 2022 | 149 | 0.040 |
Why?
| | RNA | 2 | 2007 | 925 | 0.040 |
Why?
| | Hypolipidemic Agents | 1 | 2022 | 89 | 0.040 |
Why?
| | Phospholipids | 1 | 2003 | 215 | 0.040 |
Why?
| | Autophagosomes | 1 | 2021 | 20 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 584 | 0.040 |
Why?
| | Enzyme Activation | 3 | 2011 | 758 | 0.040 |
Why?
| | Social Conditions | 1 | 2020 | 14 | 0.040 |
Why?
| | Norway | 1 | 2020 | 41 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 537 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 820 | 0.040 |
Why?
| | Proteinuria | 1 | 2021 | 103 | 0.040 |
Why?
| | Adipocytes | 1 | 2002 | 223 | 0.040 |
Why?
| | Hypophosphatemia, Familial | 1 | 2020 | 4 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2005 | 899 | 0.040 |
Why?
| | Biological Assay | 1 | 2021 | 133 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5875 | 0.040 |
Why?
| | Butadienes | 1 | 2020 | 33 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 53 | 0.040 |
Why?
| | Methotrexate | 1 | 2021 | 234 | 0.040 |
Why?
| | Retinoid X Receptors | 1 | 2020 | 41 | 0.040 |
Why?
| | Research Design | 1 | 2026 | 1139 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 294 | 0.040 |
Why?
| | Folic Acid | 1 | 2021 | 197 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 159 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 146 | 0.040 |
Why?
| | 2,4-Dinitrophenol | 1 | 2019 | 8 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2026 | 1754 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2022 | 290 | 0.040 |
Why?
| | Kidney Medulla | 1 | 2019 | 28 | 0.040 |
Why?
| | Pyrimidinones | 1 | 2020 | 124 | 0.040 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 610 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2019 | 41 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2019 | 76 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 50 | 0.040 |
Why?
| | Oxygen | 1 | 2004 | 996 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 568 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 211 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 449 | 0.040 |
Why?
| | DNA | 1 | 2005 | 1418 | 0.040 |
Why?
| | Testosterone | 1 | 2002 | 419 | 0.030 |
Why?
| | Fluorocarbons | 2 | 2012 | 122 | 0.030 |
Why?
| | Pyridones | 1 | 2020 | 210 | 0.030 |
Why?
| | Odds Ratio | 1 | 2021 | 1070 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 306 | 0.030 |
Why?
| | Urinary Tract | 1 | 2018 | 47 | 0.030 |
Why?
| | Adult | 5 | 2022 | 40821 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2012 | 1041 | 0.030 |
Why?
| | Stem Cells | 1 | 2002 | 612 | 0.030 |
Why?
| | Registries | 1 | 2026 | 2382 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 743 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 443 | 0.030 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 11 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 3538 | 0.030 |
Why?
| | Weight Loss | 1 | 2002 | 857 | 0.030 |
Why?
| | Dietary Fats, Unsaturated | 2 | 2006 | 24 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 51 | 0.030 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 200 | 0.030 |
Why?
| | Nuclear Power Plants | 1 | 2015 | 3 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 366 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8351 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 6050 | 0.030 |
Why?
| | Health Status | 1 | 2020 | 822 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2012 | 1367 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2016 | 120 | 0.030 |
Why?
| | Chemokine CXCL6 | 1 | 2014 | 2 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 384 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2016 | 195 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 606 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 326 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 384 | 0.030 |
Why?
| | Gene Expression | 3 | 2004 | 1461 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 224 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 511 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 6045 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2017 | 494 | 0.030 |
Why?
| | Fatty Acid Synthases | 2 | 2005 | 23 | 0.030 |
Why?
| | Blood Glucose | 4 | 2006 | 2357 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2013 | 27 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2018 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 31 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2910 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2014 | 105 | 0.020 |
Why?
| | Immunotherapy | 1 | 2018 | 669 | 0.020 |
Why?
| | ras Proteins | 1 | 2014 | 148 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 250 | 0.020 |
Why?
| | Lipoproteins, VLDL | 2 | 2002 | 21 | 0.020 |
Why?
| | Cytochromes c | 1 | 2012 | 53 | 0.020 |
Why?
| | beta Catenin | 1 | 2014 | 250 | 0.020 |
Why?
| | Macaca fascicularis | 1 | 2012 | 70 | 0.020 |
Why?
| | Pregnancy | 1 | 2005 | 7217 | 0.020 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 65 | 0.020 |
Why?
| | Streptozocin | 1 | 2012 | 22 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1411 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 218 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1244 | 0.020 |
Why?
| | Cholesterol Esters | 1 | 2011 | 7 | 0.020 |
Why?
| | Bone Matrix | 1 | 2011 | 6 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 28 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 608 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 542 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 423 | 0.020 |
Why?
| | Serum | 1 | 2011 | 58 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 384 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 483 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 14240 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 125 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 615 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 198 | 0.020 |
Why?
| | Epididymis | 1 | 2010 | 14 | 0.020 |
Why?
| | Flow Cytometry | 2 | 2006 | 1160 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2010 | 162 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 165 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 67 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 973 | 0.020 |
Why?
| | Oxygen Consumption | 2 | 2002 | 719 | 0.020 |
Why?
| | Stromal Cells | 1 | 2009 | 123 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 240 | 0.020 |
Why?
| | Feces | 1 | 2012 | 494 | 0.020 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2008 | 13 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 22451 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 15 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 447 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 115 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 21 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2008 | 93 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 56 | 0.020 |
Why?
| | Sporothrix | 1 | 2007 | 3 | 0.020 |
Why?
| | Paracoccidioides | 1 | 2007 | 2 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 28 | 0.020 |
Why?
| | Pigments, Biological | 1 | 2007 | 17 | 0.020 |
Why?
| | Blastomyces | 1 | 2007 | 9 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 57 | 0.020 |
Why?
| | Collagen | 1 | 2010 | 460 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 257 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 124 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2007 | 76 | 0.020 |
Why?
| | Lipid Metabolism Disorders | 1 | 2006 | 4 | 0.020 |
Why?
| | PPAR gamma | 1 | 2008 | 180 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2006 | 16 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 505 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2006 | 39 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 17291 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2006 | 25 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 541 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 41 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 84 | 0.010 |
Why?
| | Mitochondrial Membranes | 1 | 2006 | 40 | 0.010 |
Why?
| | Haplotypes | 1 | 2008 | 505 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 119 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2006 | 150 | 0.010 |
Why?
| | Octoxynol | 1 | 2005 | 12 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2006 | 190 | 0.010 |
Why?
| | Endopeptidase K | 1 | 2005 | 17 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 45 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2006 | 122 | 0.010 |
Why?
| | Acyl-CoA Oxidase | 1 | 2005 | 2 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2010 | 564 | 0.010 |
Why?
| | Ethanolaminephosphotransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2005 | 1 | 0.010 |
Why?
| | Microarray Analysis | 1 | 2005 | 117 | 0.010 |
Why?
| | Fish Oils | 1 | 2005 | 27 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2006 | 322 | 0.010 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2004 | 8 | 0.010 |
Why?
| | Thinness | 1 | 2005 | 99 | 0.010 |
Why?
| | Sphingomyelins | 1 | 2004 | 22 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 2004 | 32 | 0.010 |
Why?
| | Serine | 1 | 2005 | 142 | 0.010 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2004 | 18 | 0.010 |
Why?
| | Glycerol | 1 | 2005 | 90 | 0.010 |
Why?
| | Palmitic Acid | 1 | 2004 | 40 | 0.010 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 180 | 0.010 |
Why?
| | Catalysis | 1 | 2005 | 304 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 357 | 0.010 |
Why?
| | Homozygote | 1 | 2005 | 196 | 0.010 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2004 | 5 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2004 | 17 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 372 | 0.010 |
Why?
| | Echocardiography | 1 | 2007 | 645 | 0.010 |
Why?
| | Trans-Activators | 1 | 2006 | 371 | 0.010 |
Why?
| | Fats | 1 | 2004 | 13 | 0.010 |
Why?
| | Cysteine | 1 | 2005 | 210 | 0.010 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2004 | 17 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 403 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2004 | 154 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2005 | 214 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 225 | 0.010 |
Why?
| | Ion Channels | 1 | 2004 | 128 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2003 | 39 | 0.010 |
Why?
| | Epitopes | 1 | 2005 | 479 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6449 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2003 | 55 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 662 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 876 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 506 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1030 | 0.010 |
Why?
| | Body Temperature | 1 | 2004 | 227 | 0.010 |
Why?
| | Muscles | 1 | 2004 | 330 | 0.010 |
Why?
| | Protein Conformation | 1 | 2005 | 914 | 0.010 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 13 | 0.010 |
Why?
| | Vacuoles | 1 | 2002 | 36 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 120 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2002 | 85 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1361 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 152 | 0.010 |
Why?
| | Gene Dosage | 1 | 2002 | 146 | 0.010 |
Why?
| | Cell Size | 1 | 2002 | 94 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2004 | 263 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 423 | 0.010 |
Why?
| | Infant | 1 | 2015 | 10093 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2002 | 751 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11888 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 921 | 0.010 |
Why?
| | Eating | 1 | 2002 | 386 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1553 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2446 | 0.010 |
Why?
|
|
Miyazaki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|